WallStreetZenWallStreetZen

NASDAQ: RKDA
Arcadia Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RKDA

Based on 1 analyst offering 12 month price targets for Arcadia Biosciences Inc.
Min Forecast
$10.00+385.44%
Avg Forecast
$10.00+385.44%
Max Forecast
$10.00+385.44%

Should I buy or sell RKDA stock?

Based on 1 analyst offering ratings for Arcadia Biosciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RKDA stock forecasts and price targets.

RKDA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-05

1 of 1

Forecast return on equity

Is RKDA forecast to generate an efficient return?

Forecast return on assets

Is RKDA forecast to generate an efficient return on assets?

RKDA revenue forecast

What is RKDA's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$6.5M+21.95%

RKDA vs Food Stocks

TickerPricePrice TargetUp/downsideConsensus
RKDA$2.06$10.00+385.44%Buy
BSFC$0.07N/AN/A
NUZE$1.17N/AN/A
SNAX$1.33N/AN/A
STKH$4.50N/AN/A
View Top Food Stocks

Arcadia Biosciences Stock Forecast FAQ

Is Arcadia Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: RKDA) stock is to Buy RKDA stock.

Out of 1 analyst, 0 (0%) are recommending RKDA as a Strong Buy, 1 (100%) are recommending RKDA as a Buy, 0 (0%) are recommending RKDA as a Hold, 0 (0%) are recommending RKDA as a Sell, and 0 (0%) are recommending RKDA as a Strong Sell.

If you're new to stock investing, here's how to buy Arcadia Biosciences stock.

What is RKDA's revenue growth forecast for 2024-2024?

(NASDAQ: RKDA) Arcadia Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Packaged Foods industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Arcadia Biosciences's revenue in 2024 is $5,330,000.

In 2024, RKDA is forecast to generate $8,858,460 in revenue, with the lowest revenue forecast at $8,858,460 and the highest revenue forecast at $8,858,460.

What is RKDA's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: RKDA) forecast ROA is N/A, which is lower than the forecast US Packaged Foods industry average of 7.52%.

What is RKDA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RKDA price target, the average RKDA price target is $10.00, with the highest RKDA stock price forecast at $10.00 and the lowest RKDA stock price forecast at $10.00.

The Wall Street analyst predicted that Arcadia Biosciences's share price could reach $10.00 by Apr 5, 2025. The average Arcadia Biosciences stock price prediction forecasts a potential upside of 385.44% from the current RKDA share price of $2.06.

What is RKDA's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: RKDA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.